These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 7739538)
1. Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling. Drummond-Barbosa D; Vaillancourt RR; Kazlauskas A; DiMaio D Mol Cell Biol; 1995 May; 15(5):2570-81. PubMed ID: 7739538 [TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells. Nilson LA; Gottlieb RL; Polack GW; DiMaio D J Virol; 1995 Sep; 69(9):5869-74. PubMed ID: 7543592 [TBL] [Abstract][Full Text] [Related]
3. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein. Petti LM; Reddy V; Smith SO; DiMaio D J Virol; 1997 Oct; 71(10):7318-27. PubMed ID: 9311809 [TBL] [Abstract][Full Text] [Related]
4. Role of glutamine 17 of the bovine papillomavirus E5 protein in platelet-derived growth factor beta receptor activation and cell transformation. Klein O; Polack GW; Surti T; Kegler-Ebo D; Smith SO; DiMaio D J Virol; 1998 Nov; 72(11):8921-32. PubMed ID: 9765437 [TBL] [Abstract][Full Text] [Related]
5. The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the beta-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation. Goldstein DJ; Li W; Wang LM; Heidaran MA; Aaronson S; Shinn R; Schlegel R; Pierce JH J Virol; 1994 Jul; 68(7):4432-41. PubMed ID: 8207816 [TBL] [Abstract][Full Text] [Related]
6. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. Cohen BD; Goldstein DJ; Rutledge L; Vass WC; Lowy DR; Schlegel R; Schiller JT J Virol; 1993 Sep; 67(9):5303-11. PubMed ID: 8394451 [TBL] [Abstract][Full Text] [Related]
7. Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells. Petti L; DiMaio D J Virol; 1994 Jun; 68(6):3582-92. PubMed ID: 8189497 [TBL] [Abstract][Full Text] [Related]
8. Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor beta receptor. Lai CC; Henningson C; DiMaio D Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15241-6. PubMed ID: 9860953 [TBL] [Abstract][Full Text] [Related]
9. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein. Riese DJ; DiMaio D Oncogene; 1995 Apr; 10(7):1431-9. PubMed ID: 7731695 [TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein. Staebler A; Pierce JH; Brazinski S; Heidaran MA; Li W; Schlegel R; Goldstein DJ J Virol; 1995 Oct; 69(10):6507-17. PubMed ID: 7666552 [TBL] [Abstract][Full Text] [Related]
11. A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor. Petti LM; Talbert-Slagle K; Hochstrasser ML; DiMaio D J Biol Chem; 2013 Sep; 288(38):27273-27286. PubMed ID: 23908351 [TBL] [Abstract][Full Text] [Related]
13. Compensatory mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor β receptor reveal a complex direct transmembrane interaction. Edwards AP; Xie Y; Bowers L; DiMaio D J Virol; 2013 Oct; 87(20):10936-45. PubMed ID: 23926343 [TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein. Nilson LA; DiMaio D Mol Cell Biol; 1993 Jul; 13(7):4137-45. PubMed ID: 8321218 [TBL] [Abstract][Full Text] [Related]
15. The bovine papillomavirus E5 protein requires a juxtamembrane negative charge for activation of the platelet-derived growth factor beta receptor and transformation of C127 cells. Klein O; Kegler-Ebo D; Su J; Smith S; DiMaio D J Virol; 1999 Apr; 73(4):3264-72. PubMed ID: 10074180 [TBL] [Abstract][Full Text] [Related]
16. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation. Sparkowski J; Mense M; Anders J; Schlegel R J Virol; 1996 Apr; 70(4):2420-30. PubMed ID: 8642670 [TBL] [Abstract][Full Text] [Related]
17. E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells. Sparkowski J; Anders J; Schlegel R EMBO J; 1995 Jul; 14(13):3055-63. PubMed ID: 7621820 [TBL] [Abstract][Full Text] [Related]
18. The transmembrane domain of the E5 oncoprotein contains functionally discrete helical faces. Adduci AJ; Schlegel R J Biol Chem; 1999 Apr; 274(15):10249-58. PubMed ID: 10187811 [TBL] [Abstract][Full Text] [Related]
19. Productive interaction between transmembrane mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor beta receptor. Lai CC; Edwards AP; DiMaio D J Virol; 2005 Feb; 79(3):1924-9. PubMed ID: 15650217 [TBL] [Abstract][Full Text] [Related]
20. The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. Goldstein DJ; Andresson T; Sparkowski JJ; Schlegel R EMBO J; 1992 Dec; 11(13):4851-9. PubMed ID: 1334459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]